Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 3, 2001, Pages 572-585

  Gonzalez, Juana ^a   Harris, Tom ^a   Childs, Geoffrey ^a   Prystowsky, Michael B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

cDNA microarray; IL 2; Rapamycin; T lymphocyte

Indexed keywords

INTERLEUKIN 2; RAPAMYCIN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; IMMUNOSTIMULATION; METABOLISM; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 0034889007     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0420     Document Type: Article

References (73)

1. Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes
2. Contingent genetic regulatory events in T lymphocyte activation
3. Activation changes the spectrum but not the diversity of genes expressed by T cells
4. Sequential expression of genes involved in human T lymphocyte growth and differentiation
5. cDNA Cloning and characterization of interleukin 2-induced genes in a cloned T helper lymphocyte
6. A mammalian protein targeted by G1 arresting rapamycin receptor complex
7. RAFT1: A mammalian protein that binds to FKBP-12 in a rapamycin-dependent fashion and is homologous to yeast TORs
8. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells
9. Promoter activity of the proliferating-cell nuclear antigen gene is associated with inducible CRE-binding proteins in interleukin 2-stimulated T lymphocytes
10. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines
11. Making and reading microarrays
12. Cluster analysis and display of genome-wide expression patterns
13. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
14. Dexamethasone induces apoptosis in human T cell clones expressing low levels of bcl-2
15. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and 1ck cooperate in hematopoietic cell proliferation
16. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases
17. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis
18. Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte
19. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
20. Identification of an essential cis-element near the transcription start site for transcriptional activation of the proliferating cell nuclear antigen gene
21. The Pezcoller lecture: Cancer cell cycles revisited
22. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes
23. Interleukin-2-mediated elimination of the p27 (Kip1) cyclin-dependent kinase inhibitor prevented by rapamycin
24. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1
25. rpt-1, An intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1
26. Role of transforming growth factor beta (TGF beta) in systemic autoimmunity
27. Identification of STRAP, a novel WD domain protein in transforming growth factor-B signaling
28. Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein Ck-sHs1
29. Identification of an NTF2-regulated factor that binds ran-GTP and regulates nuclear protein export
30. Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells
31. Cloning and characterization of hTAF1118, hTAF1120 and hTAF1128: Three subunits of the human transcription factor TF11D
32. Rapamycin selectively blocks interleukin-2 induced proliferating cell nuclear antigen gene expression in T lymphocyte: Evidence for inhibition of creb/ atf binding activities
33. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes
34. Expression of a novel isoform of cyclin 1 in human testis
35. Murine betaglycan primary structure, expression and glycosaminoglycan attachment sites
36. Immunopharmacology of rapamycin
37. Implication of e1F2B rather than e1F4E in the regulation of global protein synthesis by amino acids in L6 myoblasts
38. Requirement of protein kinase Cz for stimulation of protein synthesis by insulin
39. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin
40. Regulation of eIF-4E BP1 phosphorylation by mTOR
41. Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF)
42. Cloning, expression and characterization of human metalloprotease 1: A novel member of the pitrilysin family of metalloendoproteases
43. Ubiquitination of RNA polymerase II large subunit signaled by phosphorylation of carboxy 1-terminal domain
44. Bax-mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity
45. The murine antiapoptotic protein A1 is induced in inflammatory macrophages and constitutively expressed in neutrophils
46. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
47. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
48. Transcript imaging of the development of human T helper cells using oligonucleotide arrays
49. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
50. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
51. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: Evidence for TRAIL induction via the T cell receptor signaling pathway
52. T-cell growth factors in allograft rejection and tolerance
53. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
54. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits
55. The regulation and function of p21ras during T-cell activation and growth
56. p70(s6k) Integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes
57. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression
58. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators
59. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway
60. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
61. Identification of an essential cis-element near the transcription start site for transcriptional activation of the proliferating cell nuclear antigen gene
62. The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines
63. Rapamycin resistance tied to defective regulation of p27Kip1
64. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability
65. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation
66. Isolation and analysis of a T cell clone variant exhibiting constitutively phosphorylated Ser 133 cAMP response element-binding protein
67. Requirement of nuclear prolactin for interleukin 2 stimulated proliferation of T lymphocytes
68. Requirement of PI3-kinase activity for the nuclear transport of prolactin in cloned murine T lymphocytes
69. Mechanism of TGFB receptor inhibition by FKBP12
70. Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes
71. Betaglycan presents ligand to the TGFb signaling receptor
72. Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors
73. The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo